top of page

GPCR News 

Post: Blog2_Post

Trevena Adds Seasoned Biopharma Commercial Executive to Senior Leadership Team

November 2021


"November 11, 2021 7:00am EST

Patricia Drake appointed new Chief Commercial Officer

CHESTERBROOK, Pa., Nov. 11, 2021 -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced the addition of Patricia Drake to its senior leadership team as Chief Commercial Officer." Read more at the source


1 view0 comments

Recent Posts

See All

Amgen to Acquire Chemocentryx for $4 Billion in Cash

August 2022 "THOUSAND OAKS, Calif. and SAN CARLOS, Calif., Aug. 4, 2022 /PRNewswire/ -- Amgen (NASDAQ: AMGN) and ChemoCentryx, Inc., (NASDAQ: CCXI), a biopharmaceutical company focused on orally admin

bottom of page